Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
Fish and Richardson
UBS
Mallinckrodt
Citi
Argus Health
McKinsey
QuintilesIMS

Generated: April 19, 2018

DrugPatentWatch Database Preview

SINEMET CR Drug Profile

« Back to Dashboard

When do Sinemet Cr patents expire, and when can generic versions of Sinemet Cr launch?

Sinemet Cr is a drug marketed by Merck Sharp Dohme and is included in one NDA.

The generic ingredient in SINEMET CR is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.
Drug patent expirations by year for SINEMET CR
Pharmacology for SINEMET CR
Synonyms for SINEMET CR
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid; (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid
500019-90-9
57308-51-7
AC1L2XHE
Carbidopa / Levodopa
CARBIDOPA AND LEVODOPA
Carbidopa Levodopa
Carbidopa mixture with Levodopa
Carbidopa-L-dopa mixt
Carbidopa-L-dopa mixt.
Carbidopa-levodopa (1:10)
Carbidopa-levodopa ER
Carbidopa-levodopa extended release
Carbidopa-levodopa mixt
Carbidopa-levodopa mixt.
carbidopa, levodopa drug combination
CHF 1512
Co-careldopa
CR-3
CR-5
DM-1992
Dopabain
Duodopa
Duopa
IPX 066
IPX066
Isicom
IVTMXOXVAHXCHI-YXLMWLKOSA-N
L-Tyrosine, 3-hydroxy-, mixt. with (S)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid
L-Tyrosine, 3-hydroxy-, mixt. with (S)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid (10:1)
Levodopa / carbidopa
levodopa carbidopa
Levodopa-carbidopa (10:1)
Levodopa/Carbidopa Solution
LS-158296
Nacom
Nakom
ND 0612
ND0612
Rytary
SCHEMBL2049245
Sinemet CR4

US Patents and Regulatory Information for SINEMET CR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp Dohme SINEMET CR carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 019856-002 Dec 24, 1992 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme SINEMET CR carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 019856-001 May 30, 1991 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for SINEMET CR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme SINEMET CR carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 019856-001 May 30, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme SINEMET CR carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 019856-001 May 30, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme SINEMET CR carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 019856-002 Dec 24, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme SINEMET CR carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 019856-001 May 30, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Covington
US Army
Dow
Merck
Medtronic
Citi
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.